Open Access

Alternative drugs go global: possible lead and/ or mercury intoxication from imported natural health products and a need for scientifically evaluated poisoning monitoring from environmental exposures

Journal of Occupational Medicine and Toxicology201611:49

https://doi.org/10.1186/s12995-016-0139-0

Received: 6 January 2016

Accepted: 2 November 2016

Published: 8 November 2016

Abstract

Background

With increases in globalization, cultural remedies from Chinese, Ayurvedic, Arab and other traditions have become more available to international consumers, offering unfamiliar “Natural Health Products” (NHP), used as alternative medicine or supplementary medicine.

Contamination with toxic ingredients including lead, mercury, arsenic, and other toxic elements has been documented in several of these products from various parts of the globe, particularly from some parts of Asia and the Orient.

Findings

We have been following this development in the last 6 years and have analyzed n = 20 such products (60 analyses) from patients with intoxication symptoms in a pilot study, showing alarming high concentrations of mercury and/or lead (the first one in “therapeutic” doses). 82 % of the studied NHP contained lead concentrations above the EU limit for dietary supplements. 62 % of the samples exceeded the limit values for mercury. Elevated blood lead and mercury levels in patients along with clinical intoxication symptoms corroborate the causal assumption of intoxication (s). We present one detailed clinical case report of severe lead and mercury intoxications and give an overview about blood concentration related symptoms and signs of n = 41 case reports of mercury intoxications of the German monitoring BfR-DocCenter.

Conclusions

For NHP there is evidence on a distinct toxicological risk with alarming low awareness for a possible intoxication which prevents potentially life-saving diagnostic steps in affected cases. In many cases patients do not communicate the events to their physicians or the local health authority so that case reports (e.g. the BfR-DocCentre) are missing. Thus, there is an urgent need to raise awareness and to initiate more suitable monitory systems (e.g. National Monitoring of Poisonings) and control practice protecting the public.

Keywords

Natural health products Dietary supplements Heavy metal intoxication Lead Mercury Monitoring Prevention measures

Background

Important underestimated global health issue

With the globalization, Chinese, Ayurvedic, African or Arab complementary medicine became available to international consumers [1]. People worldwide are increasingly consuming diverse natural health products, NHP (in the EU dietary supplements) with estimated 600 million visits for users of alternative medicine [1]. Patients believe that the intake of these products is safe and unlike conventional medical therapies devoid of side effects, since they assume that NHP are prepared only out of herbs, animal and/or natural minerals. Notably some natural medicine therapy schools treat in accordance with the valid doctrine “similis similibus curantur” claiming that heavy metals can be used (in supposedly safe doses) for therapeutic detoxification. Case reports show, however, heavy metal intoxication in NHP consumers worldwide [25]. American Studies [5] found in 20 % (n = 197) of such products lead, mercury and arsenic in concentrations 100–10,000 times higher than the allowable limit values. Our goal was to analyze and evaluate such natural products sent to our laboratory for indicatory analysis in the course of suspected heavy metal intoxications.

Additionally, we aimed to compare the data with intoxication cases reported to the BfR-DocCenter and reevaluate the existing data based on well documented human reports [6]. Since new data have been recently published on complex effects of elementary lead and mercury on human health our goal was to reassess the current situation in Germany with regard to the possible intoxications to lead and mercury.

Findings

Pilot study

Our pilot study is case-based, non-randomized. We have included all patients with presumed heavy metal intoxication due to NHP within 6 years refereed to us from clinical departments (i.e. neurology) for a second diagnosis. Additionally, all cases reported to the BfR-DocCenter were analyzed representing the official statistics from Germany. Limitation: since this is a case based study, we are not aware on dark figures, i.e. of non-reported cases.

The samples were analyzed in the period 2009 to 2015. Product samples were extracted using microwave –assisted process [79] with PTFE-HT tubes, HTR -300/6 s dissociation with pressure-calibration system (PCS) from MLC (Mikrowellen Laborsysteme, Leuterbach, Germany). Material samples as well as blood and urine samples were quantified using atomic absorption spectrometer [10] with automatic sampler system (Thermo Fisher Scientific, Dual AA Spectrometer ICE 3500, Freiburg, Germany). For mercury the AA method with hybrid metal mercury enhancement system was applied and lead was measured using graphite oven with Zeeman background compensation; LOD values for lead were 0.01 μg/g and for mercury 0.02 μg/g dry mass. Pb and Hg were quantified based on the ratio of analyte to that of internal standard in peak hopping mode. Two bench quality control pools were analyzed along with the samples. Signal data were analyzed with data processing software (Thermo Fisher). The internal and external quality assessment scheme followed the rules of the German guideline for human biomonitoring with external quality assessment scheme from the German Society for Occupational and Environmental Medicine www.g-equas.de. The measured day to day precision was <15 % RSD The statistical analyses were performed with Prism version 6.00 for Windows, GraphPad Software, La Jolla, California, USA.

Product analyses from patients with presumed intoxication due to NHP: symptoms included abdominal cramps, anemia, neuropathy and kidney failure (see below for a typical case presentation). 20 natural health products were measured (Pb, Hg, As content) that patients either brought from abroad or had ordered over the Internet (Fig. 1a). The remedies were analyzed by atomic absorption spectrometry (see above).
Fig. 1

Lead and/or mercury contamination in natural health products (NHP). a NHP (in the EU dietary supplements, for oral exposure road) are sold as powder, globules (in different size or pressed into tablets). B/C. Scatter plot (with box showing median values with inter quartile range) of n = 20 NHP tested for lead (b) and mercury (c) contamination. Note: dots below LOD are not shown

Eighty-two percent of the studied NHP contained lead concentrations above the EU limit (Table 1) for dietary supplements (3 μg/g). Average amounts of lead were: 35.80 μg/g, [3.59 to 17,760 μg/g for 25 % vs. 75 % percentile respectively; Median values were 45 μg/g]. 62 % of the samples exceeded the limit values for mercury (0.1 μg/g), average mercury amounts found were: 22.13 μg/g [0.06 to 46.6 μg/g for 25 % vs. 75 % percentile respectively; median: 0.43 μg/g] (Fig. 1b, c). Arsenic was detected in a single sample.
Table 1

Limit values

Heavy metal

Diagnostic analysis (biomonitoring parameter)

Reference values [μg/L]

Limit values [μg/L]

NHPc allowable limit values [μg/g]

Lead

total blood lead

60a

42b

150/250d

3

total urine lead

-

2.3b

-

Mercury

total blood mercury

2a

4.6b

5

0.1

urinary total mercury

1.0a

3.3b

7

Arsenic

total blood arsenic

-

-

n.d.

urinary total arsenic

15a

66b

n.d.

Limit values refer to adults >20 y (German Human Biomonitoring values). Reference values refer to adults: National report on human exposure to environmental chemicals, showing 95th percentile values: aGermany (https://www.umweltbundesamt.de/themen/gesundheit/kommissionen-arbeitsgruppen/kommission-human-biomonitoring/stellungnahmen-der-kommission-human-biomonitoring); bUS (http://www.cdc.gov/exposurereport/pdf/fourthreport.pdf); cEU allowable limit values for dietary supplements

n.d. not determined; dthe values are not valid after 2013 (are currently being re-evaluated)

Case report: patient with lead and mercury intoxication

Patient, male, 31 with BMI slightly below normal, non-smoker, was referred to the neurological department of the university clinic with severe peripheral poly neuropathy and sensory motor symptoms with neuropathic pain. The patient was in good general state of health until approximately 3 weeks before hospital admission; he spent his holiday in Himalaya region and came back with headaches and fatigue. He was taking pain medication without any relieve; his routine blood values were normal. He claimed to take no further medications. Since poly neuropathy and fatigue could be caused by pesticides or other poisoning, i.e. heavy metals, we have been consulted for taking a detailed exposure history. While in the clinic, 3 different NHPs were found in form of globules, (a, b, c for morning, lunch time and evening respectively), which he imported from his trip to Asia and ingested 3 times a day against stress. We have analyzed these 3 NHPs and found: 45 μg/g, 53,000 μg/g and 28 μg/g lead (for morning, midday and evening globules, respectively) and additionally 15.72 μg/g mercury in the “evening globules”. Since, his blood metal levels were: 340 μg/L Pb and 15 μg/L Hg a diagnosis of heavy metal intoxication was made. Slowly occurring clinical recovery after starting chelation therapy corroborated with the causal assumption proposed. He was released for further consultancy to his family physician. The administrated treatment and the improvement of his status corroborate lead and mercury intoxication.

Lead intoxication cases: symptoms and signs organ related

While looking closer for reported cases to the BfR-DocCenter [11], we found one similar case reported to this national poisoning report system. The case report describe female patient with neurological symptoms, radial paralysis and anemia with 880 μg/L blood lead levels after consuming lead containing NHP (with 50,400 μg lead/g) for several weeks. CDC-NIOSH funded the ABLES (adult blood lead epidemiology & surveillance) program and conducted adult blood lead levels (BLL) surveillance [12]. In 2010, ABLES program reported 31,081 adults with BLL ≥ 100 μg/L [13]. In the United States, when the exposure source is known, approximately 95 % of BLL ≥ 250 μg/L in adults are work-related (battery manufacturing, lead and zinc ore mining, painting and paper handling industries). The National Toxicology Program data have shown that low lead exposure causes acute and chronic adverse effects in multiple organ systems [14]. Beside, well known symptoms like abdominal cramps, anemia [15] also confusion, neuropathy, encephalopathy or paralyses may occur. Evidence indicates that lead exposure at low doses can lead to adverse cardiovascular and kidney effects [16] (tubular dysfunction, increased glomerular filtration rate), cognitive dysfunction and adverse reproductive outcomes. Decreased renal function is associated with BLL at 50 μg/L or lower and increased risk of hypertension and essential tremor at BLL below 100 μg/L [14]. Lead can also constrain the growth of long bones in the childhood and increase susceptibility to osteoporosis later in life [17, 18].

Mercury intoxication cases: symptoms and signs blood level related

Unlike for lead we found 41 reported cases (BfR-DocCenter-Database) with exposure to elemental and inorganic Hg (Table 2), which had been conditioned scientifically before [19]. The cases were evaluated and recorded by the BfR expert-judgment [20]. The evaluated cases were assessed with regard to the dose, standardized symptoms and signs. and categorized for health impairment following the Poison Severity Score (PSS). The causality (exposure vs. symptoms/signs) was assessed by the BfR-standard “Three-Level-Model”. Symptoms and signs were carefully assessed and aggregated in concentration-related sub- and top groups to get Hg-specific impairment pattern beside the standard PSS assessment. Additional clinical data were evaluated in terms of the different dose-response relationship among the various groups (Table 2). Nearly half the cases in which all grades of PSS (see [20] for more details) are represented have Hg blood concentration between 15 and 40 μg/L, which is only slightly above the HBM-II (German Human Biomonitoring limit values) value.
Table 2

Cases of elemental and inorganic mercury exposure (n = 41) Symptoms and signs organ related vs. Hg blood concentraton

Symptoms/signs

Mercury concentration in blood

Organ top groups

Sub-groups

≤25 μg/L

≤ 300 μg/L

≤ 3000 μg/L

Gastrointestinal

 

X

x

 

abdominal pain

X

x

Neurological

 

X

 

x

disorders of consciousness

 

x

 

neuropathy

X

x

headache

  

sweating disturbance

X

x

sleeping disturbance

X

x

memory disturbance

 

x

Neuro-psychosocial

 

X

x

x

personality disorder

X

x

 

depression

 

x

weakness

X

x

lost of weight

X

x

thirst

 

x

Muscle/ skeleton/teeth

 

X

x

 

muscle pain

X

x

teeth disorders

 

x

Cardio- vascular/blood

 

X

x

 

cardiomyopathy

 

x

body temp. elevated

X

x

panmyelopathy

X

 

blood count disorders

X

x

Respiratory

 

X

x

 

pneumo thorax

 

x

hypoventilation

X

x

acidosis

 

x

Liver/Kidney

 

X

  

hepatomegaly

 

x

kidney disorders

X

x

Skin

   

x

necrosis

X

x

alopecia

X

x

Eye

    

eye disorders

X

x

41 cases with elemental and inorganic Hg, reported to the BfR DocCenter were analysed. The cases were evaluated by the BfR expert judgement and were assesses regarding dose against the BfR standardised symptoms and signs, followed by the Poison Severity Score. The causality exposure vs symptoms was assessed by the BfR “Three-Level-Model”

Conclusions and future perspectives

Serious heavy metal intoxications from imported NHP products occurred in Germany so far only in individual cases; in comparison the rate in the US and other Asian countries is much higher. About the estimated number of unreported cases (or unrecognized cases) there are no studies. But the lead and mercury concentrations in our analyzed natural health products are alarmingly high; so the ingestion of larger amounts might be harmful and with the danger of heavy metal intoxication. Metallic mercury is naturally occurring in the environment and is often extracted from cinnabar ore. It is used in products such as thermometers, electric switches and dental fillings, as well as for the production of caustic soda and chlorine gas. Exposure to mercury often results from consumption of contaminated food sources, breast milk or cosmetic products [10]. Lead occurs naturally in the environment and has been mined for use in a variety of products, including paint, dyes, ceramic glazes, pesticides, ammunition, pipes, weights, cable covers, car batteries and sheets used for protection from radiation. Lead, is one of the nine targeted risk factors (4 % contribution in 2014) for estimated burden of diseases in Europe and recalls for 100–900 DALYs per million people in central Europe [21].

In many countries, even in Germany, no comprehensive nutria vigilance- or poisoning monitoring system exists, from which the application of natural health products and the consequent intoxication can be estimated [11]. There is also an urgent need for comprehensive scientifically evaluated studies based on efficient national monitoring to protect the consumer from heavy metal intoxications. There are no comparable surveillance systems like the US ABLES program for lead- and no surveillance systems for mercury exposures allowing any comparisons. Exposure to lead and mercury from environmental sources remains an overlooked and serious public health risk.

Declarations

Acknowledgements

The authors would like to thank Ms. Susann Finger (ZfAM, Hamburg) for skilled products extractions/technical analysis of heavy metals and Dr. Maren Prochnow (Charité, Berlin) for her excellent Master Thesis about Mercury Intoxication, Ms. Kathrin Begemann and Ms Esther Feistkorn (BfR, Berlin) for supporting expert judgment in the BfR Doc Center (causality vs. symptoms/signs).

Funding

Institutional.

Availability of data and materials

Not applicable.

Authors’ contributions

LTB: conceived the study and participated in its design and coordination. LTB supervised the laboratory data analysis, performed the statistical analysis of the data and drafted the manuscript; XB: analyzed the clinical data with exposure history and consulted external clinicians; VH: consulted external clinicians; AH: performed analysis of the BfR DocData base, appreciation of the clinical data and the toxicological risk analysis support. The authors read and approved the final manuscript.

Competing interests

The authors declare that they have no competing interests.

Consent for publication

Not applicable.

Ethic approval and consent to participate

Not applicable.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Institute for Occupational and Maritime Medicine (ZfAM), University Medical Center Hamburg-Eppendorf
(2)
Charite Institute for Occupational Medicine (CIOM), Charite-University Medicine
(3)
Federal Institute for Risk Assessment (BfR)
(4)
European Society for Environmental and Occupational Medicine (EOM)
(5)
Occupational Toxicology and Immunology, Institute for Occupational and Maritime Medicine (ZfAM), University Medical Center Hamburg-Eppendorf

References

  1. Genuis SJ, Schwalfenberg G, Siy AK, Rodushkin I. Toxic element contamination of natural health products and pharmaceutical preparations. PLoS One. 2012;7:e49676.View ArticlePubMedPubMed CentralGoogle Scholar
  2. Wu ML, Deng JF, Lin KP, Tsai WJ. Lead, mercury, and arsenic poisoning due to topical use of traditional Chinese medicines. Am J Med. 2013;126:451–4.View ArticlePubMedGoogle Scholar
  3. Saper RB, Kales SN, Paquin J, Burns MJ, Eisenberg DM, Davis RB, Phillips RS. Heavy metal content of ayurvedic herbal medicine products. JAMA. 2004;292:2868–73.View ArticlePubMedGoogle Scholar
  4. Breeher L, Mikulski M, Czeczok T, Leinenkugel K, Fuortes L. A cluster of lead poisoning among consumers of Ayurvedic medicine. Int J Occup Environ Health. 2015. [Epub ahead of print].Google Scholar
  5. Saper RB, Phillips RS, Sehgal A, Khouri N, Davis RB, Paquin J, Thuppil V, Kales SN. Lead, mercury, and arsenic in US- and Indian-manufactured ayurvedic medicines sold via the internet. JAMA. 2008;300:915–23.View ArticlePubMedPubMed CentralGoogle Scholar
  6. Hahn A, Begemann K, Stürer A. Vergiftungen in deutschland krankheitsbegriff, dokumentation und einblicke in das geschehen. Bundesgesundheitsbl, Springer-Verlag, Berlin Heidelberg. 2014;57:638–49.Google Scholar
  7. Pare JRJ, Belanger JMR, Stafford S. Microwave-assisted process (MAP): a new tool for the analytical laboratory. TrAC Trends Anal Chem. 1994;13:176–84.View ArticleGoogle Scholar
  8. Heinrich-Ramm R, Mindt-Prufert S, Szadkowski D. Arsenic species excretion after controlled seafood consumption. J Chromatogr B Analyt Technol Biomed Life Sci. 2002;778:263–73.View ArticlePubMedGoogle Scholar
  9. Heinrich-Ramm R, Schaller H, Horn J, Angerer J. Arsenic species excretion after dimercaptopropanesulfonic acid (DMPS) treatment of an acute arsenic trioxide poisoning. Arch Toxicol. 2003;77:63–8.View ArticlePubMedGoogle Scholar
  10. Hermann KU, Varwig-Janßen D, Budnik LT, Nordholt G, Reinshagen K, Oh J, Santer R, Mühlhausen C. Spezifische symptomkombination der chronischen quecksilberintoxikation. Monatsschr Kinderheilkd. 2015;04:1–4.Google Scholar
  11. Begemann K, Feistkorn E, Friedemann M, Gessner M, Hillebrand J, Keipert R, Kolbusa R, Hahn A. Cases of poisoning reported by physicians in 2010 poison and product documentation centre at the federal institute for risk assessment, Berlin. 2010.Google Scholar
  12. Alarcon WA. Summary of notifiable noninfectious conditions and disease outbreaks: elevated blood lead levels among employed adults - united states, 1994-2012. MMWR Morb Mortal Wkly Rep. 2015;62:52–75.View ArticlePubMedGoogle Scholar
  13. CDC. Adult Blood Lead Epidemiology & Surveillance (Ables). https://wwwcdcgov/niosh/topics/ables/. Accessed 29 June 2016.
  14. National-Toxicology-Program. Health effects of low-level lead. 2012. http://ntpniehsnihgov/ntp/ohat/lead/final/monographhealtheffectslowlevellead_newissn_508pdf. Accessed 29 June 2016.Google Scholar
  15. Friedman LS, Simmons LH, Goldman RH, Sohani AR. Case records of the Massachusetts general hospital. Case 12-2014. A 59-year-old man with fatigue, abdominal pain, anemia, and abnormal liver function. N Engl J Med. 2014;370:1542–50.View ArticlePubMedGoogle Scholar
  16. Kwon SY, Bae ON, Noh JY, Kim K, Kang S, Shin YJ, Lim KM, Chung JH. Erythrophagocytosis of lead-exposed erythrocytes by renal tubular cells: possible role in lead-induced nephrotoxicity. Environ Health Perspect. 2015;123:120–7.View ArticlePubMedGoogle Scholar
  17. Garcia-Esquinas E, Navas-Acien A, Perez-Gomez B, Artalejo FR. Association of lead and cadmium exposure with frailty in US older adults. Environ Res. 2015;137:424–31.View ArticlePubMedGoogle Scholar
  18. Tsai TL, Pan WH, Chung YT, Wu TN, Tseng YC, Liou SH, Wang SL. Association between urinary lead and bone health in a general population from Taiwan. J Expo Sci Environ Epidemiol. 2016;26:481-7.Google Scholar
  19. Prochnow M. Intoxications with metalic mercury-comparable evaluation of human intoxication cases. Berlin: GE. Masterthesis, Charité, University of Medicine; 2014.Google Scholar
  20. Hahn A, Prochnow M, Begemann K, Feistkorn E. Evaluation of human case series with elemental and inorganic mercury exposure in contrast to german Human-Biomonitoring (HBM) values. EAPCCT Congress proceedings. 2015.Google Scholar
  21. Hanninen O, Knol AB, Jantunen M, Lim TA, Conrad A, Rappolder M, Carrer P, Fanetti AC, Kim R, Buekers J, et al. Environmental burden of disease in Europe: assessing nine risk factors in six countries. Environ Health Perspect. 2014;122:439–46.PubMedPubMed CentralGoogle Scholar

Copyright

© The Author(s). 2016

Advertisement